Waxman to Head Hey House Committee - - BioPharm International

ADVERTISEMENT

Waxman to Head Hey House Committee


BioPharm Bulletin

In the Obama administration, an important ally in the House for Tom Daschle, who is expected to be named secretary of the Department of Health and Human Services, will be Rep. Henry Waxman (D-CA), who unseated John Dingell (D-MI), the long-time top Democrat on the House Energy and Commerce Committee, to become the panel’s new chairman. The House Democratic caucus backed Waxman for the job after a hotly contested campaign in which Waxman claimed to be better positioned to work with the new Obama administration to enact environmental and healthcare legislation.

The change puts a long-time critic of the pharmaceutical industry at the helm of this all-important panel. All healthcare legislation falls under its purview, along with measures affecting FDA and other federal health agencies. Both Dingell and Waxman have long championed universal healthcare, but differed more notably on environmental and clean air policy. A top priority for the new chairman will be to pursue health reform legislation vigorously.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here